Otsuka Holdings Co., Ltd. (OTSKF)
OTCMKTS · Delayed Price · Currency is USD
44.40
0.00 (0.00%)
Sep 4, 2025, 8:00 PM EDT
Otsuka Holdings Revenue
Otsuka Holdings had revenue of 597.93B JPY in the quarter ending June 30, 2025, with 1.44% growth. This brings the company's revenue in the last twelve months to 2.40T, up 10.17% year-over-year. In the year 2024, Otsuka Holdings had annual revenue of 2.33T with 15.42% growth.
Revenue (ttm)
2,401.70B JPY
Revenue Growth
+10.17%
P/S Ratio
1.82
Revenue / Employee
67.96M JPY
Employees
35,338
Market Cap
30.33B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,329.86B | 311.29B | 15.42% |
Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
HealthLynked | 2.58M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
Otsuka Holdings News
- 5 weeks ago - Otsuka Corporation (OSUKF) Q1 FY2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Otsuka Holdings Co., Ltd. (OTSKY) Q2 FY2024 Earnings Call Transcript - Seeking Alpha